Welcome Interstate Managers

Global health planning for ongoing and future pandemics will require continued evaluation of condensed data aggregation. We want to be selective and smart about what we badger about. The current indicators tell a global story, and one of the main narratives is that of the data not available. 50% of countries do not have data on whether or not they have infection prevention in long term care, 67% of countries have no data on whether or not they have occupational health for workers, 45% of countries have no data on whether or not they have national IPC programs and WASH standards, and so forth. There's a lot that we have no data on, a lot that individual countries have no data about themselves on. Let's improve.  Let's badger about obtaining the basics of the listed indicators, funding to obtain and be accountable to these indicators, and alignment of details of the indicators.  As a global group: We should shoulder burden. Countries with indicator ease should shoulder some b...

The current pandemic provides an opportunity offer we shouldn't refuse. Global alignment in regulatory processes for medicines has been slow. We should put funding and resources into refining the processes now, for the coming years of COVID management and for the next pandemic, outbreak or global emergency.  It is refreshing to see WHO and ICMRA step up to the plate. They need unified support and resource-intensive investment, however.  The world should examine WHO/ICMRA joint priorities, invest in labor for ICMRA and industry liaisons, and request polished organization.  Priorities around well-designed clinical trials, endpoint and safety data strategies, sharing data for multi-country approvals, incorporating ICMRA regulatory agility in policies and protocols, supporting rapid response for global emergencies, transparency of trial results, strengthening public trust in vaccines, supporting the mitigation and prevention of drug shortages, COVID therapeutic surveillance,...

Because our world did not plan properly for endurance, stamina and pandemic fatigue, we should take a few moments to spotlight positive bests.  Some governance has been at their best during COVID-19, having stepped up to the plate in a big way.  World economists have remained balanced and rationale in an otherwise turbulent, emotional time. Here we can pause and reflect on economist continued efforts behind the scenes, at advisory tables, likely repeating insight over and over. They continue to condense language for consumers as well. When we pause to consider how we function At Our Best, as a world, we can identify economist recommendations for continued trek. This is such great work:  http://www.oecd.org/economic-outlook We should continue to fund and increase funding for OECD analyses of country economies, ask for policy comparison inclusion and use this work for future pandemic/outbreak forecasting.  We should increase funding for analyses on algorithms that can ...